Seeing Is Believing

Currently out of the existing stock ratings of James Lee, 323 are a BUY (64.34%), 16 are a SELL (3.19%), 163 are a HOLD (32.47%).
Analyst James Lee, carries an average stock price target met ratio of 60.57% that have a potential upside of 36.63% achieved within 168 days. Previously, James Lee worked at MIZUHO, CLSA.
James Lee’s has documented 1,111 price targets and ratings displayed on 53 stocks. The coverage was on Communication Services, Consumer Cyclical, Healthcare, Technology, Financial Services sectors.
Most recent stock forecast was given on TCOM, Trip.com Group Ltd ADR at 25-Jun-2026.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Feb-2026
$125
$-7.85 (-5.91%)
$122
1 months 27 days ago
(11-May-2026)
2/7 (28.57%)
$-12.05 (-8.79%)
19
Buy Since 05-May-2025
$162
$29.15 (21.94%)
$150
1 months 27 days ago
(11-May-2026)
14/24 (58.33%)
$24.95 (18.21%)
89
Buy Since 20-Apr-2022
$175
$42.15 (31.73%)
$158
2 months ago
(08-May-2026)
14/18 (77.78%)
$33.51 (23.68%)
152
Buy Since 11-Apr-2024
$160
$27.15 (20.44%)
$145
2 months ago
(08-May-2026)
3/10 (30%)
$18.51 (13.08%)
154
Buy Since 08-May-2026
$173
$40.15 (30.22%)
$170
2 months ago
(08-May-2026)
13/16 (81.25%)
$31.51 (22.27%)
30
Which stock is James Lee is most bullish on?
Which stock is James Lee is most reserved on?
What Year was the first public recommendation made by James Lee?